Literature DB >> 1001355

Lack of relationship between serum free fatty acids and impaired plasma protein binding of diphenylhydantoin in chronic renal failure.

I Odar-Cederlöf, O Borgå.   

Abstract

The plasma protein binding of diphenyldantoin (DPH) in 13 patients with varying degrees of renal failure was considerably less than in normal healthy subjects confirming early studies. The fraction of unbound DPH was correlated with serum creatinine (r = 0.81, p less than 0.001), but there was no significant correlation with the serum concentration of free fatty acids, triglycerides or cholesterol.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1001355     DOI: 10.1007/bf00563076

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  19 in total

1.  Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function.

Authors:  M M Reidenberg; I Odar-Cederlöf; C von Bahr; O Borgå; F Sjöqvist
Journal:  N Engl J Med       Date:  1971-07-29       Impact factor: 91.245

2.  Plasma protein binding of diphenylhydantoin in man. Interaction with other drugs and the effect of temperature and plasma dilution.

Authors:  P K Lunde; A Rane; S J Yaffe; L Lund; F Sjöqvist
Journal:  Clin Pharmacol Ther       Date:  1970 Nov-Dec       Impact factor: 6.875

3.  Effect of in vivo elevation of free fatty acids on protein binding of drugs.

Authors:  R Gugler; D W Shoeman; D L Azarnoff
Journal:  Pharmacology       Date:  1974       Impact factor: 2.547

4.  The alteration of plasma proteins in uremia as reflected in their ability to bind digitoxin and diphenylhydantoin.

Authors:  D W Shoeman; D L Azarnoff
Journal:  Pharmacology       Date:  1972       Impact factor: 2.547

5.  Interindividual differences in the protein binding of sulfonamides: the effect of disease and drugs.

Authors:  A H Anton; W T Corey
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1971

6.  Lipid metabolism in acute and chronic renal failure.

Authors:  M S Losowsky; D H Kenward
Journal:  J Lab Clin Med       Date:  1968-05

7.  The Stockholm prospective study. 1. The initial values for plasma lipids.

Authors:  L A Carlson; S Lindstedt
Journal:  Acta Med Scand Suppl       Date:  1968

8.  Effect of chronic renal failure and hemodialysis on carbohydrate metabolism.

Authors:  C L Hampers; J S Soeldner; P B Doak; J P Merrill
Journal:  J Clin Invest       Date:  1966-11       Impact factor: 14.808

9.  The displacement of phenylbutazone-14C and warfarin-14C from human albumin by various drugs and fatty acids.

Authors:  H M Solomon; J J Schrogie; D Williams
Journal:  Biochem Pharmacol       Date:  1968-01       Impact factor: 5.858

10.  Kinetics of salicylate elimination by anephric patients.

Authors:  D T Lowenthal; W A Briggs; G Levy
Journal:  J Clin Invest       Date:  1974-11       Impact factor: 14.808

View more
  2 in total

Review 1.  Protein binding of coumarin anticoagulants in disease states.

Authors:  K Bachmann; R Shapiro
Journal:  Clin Pharmacokinet       Date:  1977 Mar-Apr       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of phenytoin.

Authors:  A Richens
Journal:  Clin Pharmacokinet       Date:  1979 May-Jun       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.